P450-Glo CYP3A4 Screening System with Luciferin-IPA from Promega

Product Specs
ItemP450-Glo CYP3A4 Screening System with Luciferin-IPA
CompanyPromega
Price Supplier Page View Company Product Page
Catalog NumberV9920
Quantity1,000 assays
MethodHomogeneous, luminescent method
DetectionLuciferin

Add to Compare List

Promega

2800 Woods Hollow Rd

Madison, WI 53711

United States

Phone: Tel: +1 (608) 274-4330
Fax: +1 (608) 277-2516

Email: custserv@promega.com
techserv@promega.com

Company Profile

Website: http://www.promega.com

(1) Modulatory Effects of Atractylodin and β-Eudesmol on Human Cytochrome P450 Enzymes: Potential Drug-Drug InteractionsMoleculesMarch 31, 2023Artitaya Thiengsusuk, Tullayakorn Plengsuriyakarn, Kesara Na-BangchangCA, USA). RQ1 RNase-Free DNase and P450-Glo™ Screening System (Cat. V9770, V9790, V9880, V9890, and V9920) were supplied by Promega (Madison, WI, USA). HPLC grade methanol was supplied by Fisher Scientific

(2) Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver DiseaseMoleculesMay 25, 2022Suvarna H. Pagire et al.P450-Glo CYP2C19 (Catalog# V9880), P450-Glo CYP 2D6 (Catalog# V9890), and P450-Glo CYP3A4 (Catalog# V9920) were attained from Promega Corp. (Madison, WI). α-naphthoflavone, sulfaphenazole, amitriptyline, quinidine,

(3) Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0Frontiers in ImmunologyJanuary 28, 2021Yvonne Grobben et al.and CYP2D6 enzymes was determined with the P450-Glo™ Screening System with Luciferin-IPA (Promega, #V9920 and V9890). For determination of IC50 values, the effect of inhibitors was determined in 10-point duplicate

(4) Discovery of Tricyclic Pyranochromenone as Novel Bruton’s Tyrosine Kinase Inhibitors with In Vivo Antirheumatic ActivityInternational Journal of Molecular SciencesOctober 25, 2020Hyewon Cho, Eun Lee, Hye Ah Kwon, Lee Seul, Hui-Jeon Jeon, Ji Hoon Yu, Jae-Ha Ryu, Raok JeonV9880; P450-Glo™ CYP2D6 Screening System—Cat. No. V9890; and P450-Glo™ CYP3A4 Screening System—Cat. No. V9920 from Promega, USA). 3.7. In Vivo Antirheumatic Activity The animal study was approved by the Institutional

(5) Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approachesRSC AdvancesOctober 10, 2018Xiaocong Pang, Baoyue Zhang, Guangyan Mu, Jie Xia, Qian Xiang, Xia Zhao, Ailin Liu, Guanhua Du, Yimin Cuithat the reliability of the docking model. 2.6 CYP3A4 inhibition assay CYP3A4-Glo™ Screening System (V9920) (Promega Corporation, Madison, WI, USA) provides a complete set of reagents for performing luminescent

(6) Relationships among ergot alkaloids, cytochrome P450 activity, and beef steer growthFrontiers in ChemistryMarch 11, 2015Charles F. Rosenkrans, Nicholas S. Ezell0, 20, and 40 µM. Enzyme activity for CYP450 was assayed using the Promega P450-Glo assay (product # V9920; Cali et al., 2009). Briefly, sample (12.5 µL) was added in triplicate to a 96-well plate, followed

(7) Production of hepatocyte-like cells from human pluripotent stem cellsNature protocolsFebruary 1, 2013Hannan NR, Segeritz CP, Touboul T, Vallier L.10011125) Albumin Blue (Active Motif 15002) A1AT ELISA Kit (AbCam AB108799) P450 Glo Assay (Promega V9920, V9770, V9790) Primers Sequence for Q-PCR are given in Supplementary Table 1 EQUIPMENT Inverted Microscope

Be the First to Write a Review!